Galcanezumab (LY 2951742) is a humanized IgG4 monoclonal antibody against the CGRP ligand. Galcanezumab can be used for migraine or cluster headaches research[1].
Molecular Weight:
(145.5 kDa)
Purity:
98.00
CAS Number:
[1578199-75-3]
Target:
CGRP Receptor
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted